Literature DB >> 27003383

Role of kisspeptin in polycystic ovary syndrome (PCOS).

Ozlen Emekci Ozay1, Ali Cenk Ozay1, Berrin Acar2, Erkan Cagliyan2, Mustafa Seçil3, Tuncay Küme4.   

Abstract

OBJECTIVE: Due to the complex relationship between kisspeptin and the hypothalamic-pituitary-gonadal axis, the study was planned to measure the kisspeptin levels in polycystic ovary syndrome (PCOS) and to analyze the correlations between kisspeptin and PCOS-related reproductive, metabolic changes.
METHODS: The study was designed as a prospective study in Dokuz Eylul University between December 2011 and September 2013. A total of 285 PCOS cases and 162 controls were recruited. After the antropometric measeruments and physcial examination, blood samples were taken for biochemical analysis.
RESULTS: PCOS group's mean BMI was 24.32 ± 3.40 and for the control group, BMI value was 23.44 kg/m2 ± 4.08 (p = 0.351). PCOS patients' FSH level was 5.10 ± 2.01 mIU/L, LH value was 7.75 ± 4.31 mIU/mL, LH/FSH ratio was 1.70 ± 1.28, DHEAS value was 221.84 ± 105.02 mg/dl, total testosterone value was 50.51 ± 27.93 ng/ml, free testosterone value was 2.52 ± 1.05 pg/ml, SHBG was 63.74 ± 45.62 nmol/L, LDL was 102.56 ± 23.45 mg/dL, HDL value was 51.36 ± 12.15 mg/dL, total cholesterol value was 214.85 ± 39.27 mg/dL, triglyceride value was 112.95 ± 46.88 mg/dL, Apo A1 value was 171.30 ± 35.35 mg/dL, Apo B value was 71.08 ± 19.07 mg/dL, Apo B/A1 ratio was 0.42 ± 0.14, free androgen index was 13.77 ± 14.15, fasting glucose value was 80.68 ± 13.80 mg/dL, fasting insulin levels was 14.13 ± 9.11 μiU/mL, HOMA-IR index was 2.76 ± 2.34, AMH value was 5.93 ± 3:33 in ng/ml, and found to be significantly higher (p < 0.001). Leptin value was 9.71 ± 5.54 pg/ml and kisspeptin value was 1.92 ± 1.29 ng/ml, respectively. Kisspeptin and leptin levels showed no statistically significant difference with control group and PCOS group. In all PCOS patients, kisspeptin showed positive correlations between LH and leptin levels.
CONCLUSION: In this study, kisspeptin had a positive correlation with LH and leptin levels in PCOS. In fact, the serum levels of kisspeptin and leptin does not differ statistically between PCOS and healthy women. There are limited data in the literature with regard to changes in kisspeptin levels and its relation with metabolic and hormonal disturbances.

Entities:  

Keywords:  Insulin resistance; kisspeptin; leptin; polycystic ovary syndrome

Mesh:

Substances:

Year:  2016        PMID: 27003383     DOI: 10.3109/09513590.2016.1161019

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  10 in total

1.  Influence of KISS1 gene polymorphisms on the risk of polycystic ovary syndrome and its associated variables, in Saudi women.

Authors:  Maha H Daghestani; Mazin H Daghestani; Mamoon Daghistani; Khushboo Ambreen; Fadwa S Albalawi; Lina M AlNeghery; Arjumand S Warsy
Journal:  BMC Endocr Disord       Date:  2020-05-07       Impact factor: 2.763

Review 2.  Hypothalamic Kisspeptin Neurons: Integral Elements of the GnRH System.

Authors:  Vikash Prashar; Tania Arora; Randeep Singh; Arti Sharma; Jyoti Parkash
Journal:  Reprod Sci       Date:  2022-07-07       Impact factor: 3.060

3.  Kisspeptin Variations in Patients with Polycystic Ovary Syndrome-A Prospective Case Control Study.

Authors:  Mona Akad; Răzvan Socolov; Cristina Furnică; Roxana Covali; Catalina Daniela Stan; Eduard Crauciuc; Ioana Pavaleanu
Journal:  Medicina (Kaunas)       Date:  2022-06-08       Impact factor: 2.948

4.  Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome.

Authors:  Manal Madany Abdalqader; Shatha Sami Hussein
Journal:  Obstet Gynecol Int       Date:  2020-09-25

5.  Transcriptome Profiling of Oocytes at the Germinal Vesicle Stage from Women from Mongolia with Polycystic Ovary Syndrome.

Authors:  Chen Du; Xiujuan Chen
Journal:  Int J Gen Med       Date:  2021-08-12

6.  Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS.

Authors:  Mazin H Daghestani; Maha H Daghestani; Arjumand Warsy; Afaf El-Ansary; Mohammed A Omair; Maha A Omair; Lena M Hassen; Eman Mh Alhumaidhi; Bashaer Al Qahtani; Abdel Halim Harrath
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-26       Impact factor: 5.555

7.  Kisspeptin and LH pulsatile temporal coupling in PCOS patients.

Authors:  Krzysztof Katulski; Agnieszka Podfigurna; Adam Czyzyk; Blazej Meczekalski; Alessandro D Genazzani
Journal:  Endocrine       Date:  2018-05-04       Impact factor: 3.633

8.  Polycystic ovary syndrome (PCOS) and kisspeptin - A Sri Lankan study.

Authors:  B Umayal; S N Jayakody; N V Chandrasekharan; W Ss Wijesundera; C N Wijeyaratne
Journal:  J Postgrad Med       Date:  2019 Jan-Mar       Impact factor: 1.476

9.  The Correlation between Hormonal Disturbance in PCOS Women and Serum Level of Kisspeptin.

Authors:  Razaw O Ibrahim; Shirwan H Omer; Chro N Fattah
Journal:  Int J Endocrinol       Date:  2020-01-07       Impact factor: 3.257

10.  Expression of the anti-Mullerian hormone, kisspeptin 1, and kisspeptin 1 receptor in polycystic ovary syndrome and controlled ovarian stimulation rat models.

Authors:  Ali Risvanli; Halis Ocal; Necati Timurkaan; Pinar Ipek; Ibrahim Seker; Burak Karabulut
Journal:  Bosn J Basic Med Sci       Date:  2020-02-05       Impact factor: 3.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.